Screener
Emergent Biosolutions EBS Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Product and services sales, net | $226.8 | $130.3 | $376.5 | $339.4 |
| Contracts and grants | 7.5 | 10.6 | 13.9 | 23.7 |
| Total revenues | 234.3 | 140.9 | 390.4 | 363.1 |
| Operating expenses: | ||||
| Cost of product and services sales, net (1) | 97.1 | 66.9 | 169.1 | 155.4 |
| Research and development | 9.2 | 12.5 | 19.7 | 27.6 |
| Selling, general and administrative | 44.6 | 43.7 | 91.2 | 96.1 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's total revenue?
- Emergent Biosolutions (EBS) reported total revenue of $234.3M in Q2 2026.
- How has Emergent Biosolutions's total revenue changed year-over-year?
- Emergent Biosolutions's total revenue increased by 66.3% year-over-year, from $140.9M to $234.3M.
- What is the long-term trend for Emergent Biosolutions's total revenue?
- Over 4 years (2021 to 2025), Emergent Biosolutions's total revenue has grown at a -19.6% compound annual growth rate (CAGR), from $1.77B to $742.9M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Emergent Biosolutions's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude